Clinical Trial Update: Efficacy and Safety of Pomalidomide in Combination With Low-dose Dexamethasone in Chinese Patients With Relapsed and Refractory Multiple Myeloma [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating pomalidomide in combination with low-dose dexamethasone for Chinese patients with relapsed and refractory multiple myeloma; efficacy an…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• DEXAMETHASONE (Dexamethasone)
• Pomalidomide (Pomalidomide)

Snippet

Sponsor: Jiangsu Simcere Pharmaceutical Co., Ltd. | Conditions: Multiple Myeloma | Phase 3 | Status: UNKNOWN